Drug intelligence / Profile preview

Perisolv

Development stage
Phase 4
Lead developer
REGEDENT
Modality
Small Molecules
Administration
Topical
01

Overview

Perisolv is a topical antiseptic cleaning gel composed of sodium hypochlorite activated with amino acids, which creates a chloramine-based formulation. Developed by Regedent AG and clinically evaluated in studies at the University of Witten/Herdecke, it is designed as an adjunctive therapy for the non-surgical treatment of periodontitis. The gel functions as a 'biofilm eraser' by chemically altering and softening the bacterial biofilm matrix within periodontal pockets. This action facilitates the more effective mechanical removal of bacteria and debris during subgingival scaling and root planing (SRP). In clinical practice, Perisolv is often applied subgingivally for 30–45 seconds prior to instrumentation and is frequently used in combination with cross-linked hyaluronic acid (such as hyaDent BG) to enhance tissue healing and pocket depth reduction.

Brand names
Perisolv
Other names
sodium hypochlorite/amino acid gelchloramine-based gel
02

Targets

eDNA (Extracellular DNA)

Beyond the preview

Go deeper on Perisolv.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Perisolv.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call